AI-Based Medical Imaging Market

Overview

The AI-Based Medical Imaging Market was valued at USD 1.86 billion in 2025 and is projected to reach USD 20.19 billion by 2034, growing at a CAGR of 30.4% during the forecast period (2026–2034). The market is driven by the increasing adoption of AI for faster diagnosis, improved imaging accuracy, and workflow automation. The market is shifting from narrow, single-finding detection algorithms toward broader foundation models capable of covering dozens of clinical indications from a single CT or X-ray study, reducing the number of point solutions health systems must separately validate, purchase, and integrate into their picture archiving and communication systems. Regulatory clarity is accelerating this shift, with a well-established and growing FDA authorization pathway giving vendors a clear route to commercialization and giving health systems confidence to move AI imaging tools from pilot programs into routine clinical use. By region, North America held the largest share of the market in 2025, supported by the concentration of FDA-cleared AI imaging vendors and early hospital adoption, while Asia Pacific is projected to be the fastest-growing region through 2034, driven by government-backed cancer-screening mandates and rapidly expanding imaging infrastructure investment across the region.

Market Size & Share

Market Dynamics

KEY MARKET TREND

Consolidation Around Multi-Indication Foundation Models Emerging as a Transformational Trend

• Radiology AI vendors are training foundation models on large volumes of CT and X-ray studies covering many clinical indications simultaneously, reducing the number of separate point-solution algorithms that health systems must validate and integrate.
• Multi-vendor interoperability standards are increasingly allowing AI imaging algorithms to plug directly into existing picture archiving and communication systems, reducing integration costs that previously slowed hospital adoption.
• Vendors are extending AI imaging platforms beyond detection and triage into automated draft-report generation, aiming to compress the full workflow from image acquisition to radiologist-reviewed report within a single integrated system.
• Well-funded entrants from outside traditional medical imaging are beginning to test the category's boundaries, bringing consumer-technology-scale capital and engineering approaches to hardware and software problems that established imaging OEMs have historically owned.

KEY MARKET DRIVER

Rising Diagnostic Imaging Volumes and Radiologist Shortages Are the Key Driver

• Growing imaging volumes tied to an aging population and rising prevalence of chronic diseases are outpacing the capacity of the existing radiologist workforce, creating direct demand for AI tools that triage and prioritize urgent findings.
• The projected U.S. radiologist shortfall, expected to reach approximately 19,500 by 2034, is pushing health systems toward AI-based workflow triage as a practical near-term response rather than waiting on workforce expansion alone.
• Faster regulatory clearance pathways and cloud-hosted imaging archives are shortening AI imaging purchasing cycles, allowing health systems to move from pilot deployment to enterprise-wide rollout more quickly than in prior years.
• The FDA had authorized 1,451 AI-enabled medical devices by the end of 2025, including 295 new authorizations in 2025 alone, with radiology accounting for approximately 76% of all AI-enabled device clearances to date, reflecting the regulatory maturity now underpinning hospital purchasing decisions.

Key Market Opportunity

Expansion into Cardiology, Pathology, and Point-of-Care Ultrasound Creates Significant Market Opportunity

• AI imaging platforms originally built for radiology are expanding into cardiology and vascular care, where time-sensitive conditions such as stroke and pulmonary embolism benefit disproportionately from automated triage and care-team coordination.
• Digital pathology is emerging as a distinct and comparatively underpenetrated AI imaging category, as oncology-focused platforms extend computer vision techniques from radiology into tissue-slide analysis.
• Point-of-care and handheld ultrasound devices integrated with AI guidance are expanding diagnostic imaging capability into primary care and lower-resource settings that previously lacked access to radiologist-supported imaging.
• Institutional and strategic capital, including corporate venture arms of major semiconductor and cloud infrastructure companies, is increasingly flowing into foundation-model-based imaging AI vendors seeking to expand beyond their original clinical indications into adjacent specialties.

AI-Based Medical Imaging Market Size, 2025-2034 (USD Billion)

Segmentation Analysis

Analysis by Technology

Deep Learning held the largest market position in 2025, driven by the widespread use of convolutional neural network (CNN) architectures for identifying and extracting diagnostically relevant patterns from complex medical images. Its ability to process large volumes of imaging data, detect subtle abnormalities, and improve the accuracy and consistency of image interpretation has made deep learning a preferred technology across radiology, pathology, and other image-intensive diagnostic workflows. Furthermore, the growing adoption of deep learning-based solutions in FDA-cleared AI medical imaging devices has strengthened its clinical acceptance and regulatory standing compared with alternative machine learning approaches.

Generative AI is projected to grow at the fastest rate during the forecast period, supported by the increasing integration of AI-powered automation into medical imaging workflows. Vendors are expanding beyond conventional detection and classification capabilities toward automated draft-report generation, image enhancement, synthetic image reconstruction, and personalized clinical insights. Growing investment in generative AI technologies, combined with their potential to reduce reporting time, improve workflow efficiency, and support radiologists in interpreting complex medical images, is expected to accelerate adoption across diagnostic imaging applications.

Technology categories include

• Deep Learning (Dominating Segment)
• Generative AI (Highest Growth Segment)
• Other Machine Learning

Analysis by Modality

CT Scan held the largest market position in 2025, supported by the ability of CT imaging to generate large, information-rich volumetric datasets that are well suited to AI-based automated triage, image analysis, and quantitative assessment. The extensive adoption of AI solutions for CT-based applications, including detection of abnormalities, prioritization of critical cases, and workflow automation, has further strengthened the modality’s position. In addition, established AI medical imaging vendors such as Aidoc have developed FDA-cleared solutions for CT-based triage use cases, contributing to the technology’s clinical adoption and integration into radiology workflows.

Ultrasound is projected to grow at the fastest rate during the forecast period, driven by the expansion of point-of-care imaging and the growing integration of real-time AI-guided image acquisition. AI-assisted ultrasound can help non-specialist operators obtain diagnostically useful images by providing guidance during scanning and supporting image quality assessment. These capabilities are expected to expand ultrasound adoption across primary care, emergency care, remote healthcare environments, and lower-resource settings where access to specialized imaging professionals may be limited.

Modality categories include

• CT Scan (Dominating Segment)
• Ultrasound (Highest Growth Segment)
• MRI
• X-Ray
• Nuclear Imaging
• Analysis by Application

Neurology held the largest application position in 2025, supported by the early concentration of AI-based medical imaging development on time-sensitive neurological conditions, particularly stroke. AI-powered imaging solutions can assist in the rapid detection and prioritization of abnormalities, automate image analysis, and alert care teams to suspected critical cases, helping accelerate clinical decision-making and reduce treatment delays. The strong integration of these capabilities into emergency stroke workflows has contributed to the widespread adoption of AI imaging technologies across neurological applications.

Cardiology is projected to grow at the fastest rate during the forecast period, driven by the expanding use of AI for cardiovascular image analysis, automated triage, and quantitative assessment. Vendors are increasingly extending AI capabilities from established neurovascular applications into coronary artery disease, structural heart conditions, and other cardiovascular disorders. High imaging volumes, the need for rapid diagnosis, and the growing availability of cardiac imaging data are expected to support wider adoption of AI solutions across cardiology workflows.

Application categories include

• Neurology (Dominating Segment)
• Cardiology (Highest Growth Segment)
• Respiratory & Pulmonary
• Breast Screening
• Orthopedics
• Others

Analysis by End User

Hospitals held the largest end-user position in 2025, supported by their concentration of complex and high-acuity imaging procedures across radiology, neurology, cardiology, and emergency care. Their need to manage large imaging volumes, prioritize time-sensitive cases, and integrate AI into existing clinical workflows has encouraged investment in enterprise-level AI imaging platforms. Greater access to advanced imaging infrastructure, specialized clinical teams, and technology budgets has further strengthened the adoption of AI-based medical imaging solutions within hospitals.

Diagnostic Imaging Centers are projected to grow at the fastest rate during the forecast period, driven by increasing adoption of AI-powered triage, image analysis, and workflow automation among standalone imaging providers. These technologies can help imaging centers improve examination turnaround times, streamline radiologist workflows, and maintain consistent diagnostic processes. As competition with hospital-based imaging departments increases, independent centers are expected to invest more heavily in AI solutions to enhance operational efficiency and strengthen service capabilities.

End User categories include

• Hospitals (Dominating Segment)
• Diagnostic Imaging Centers (Highest Growth Segment)
• Ambulatory Surgical Centers

By Region

AI-Based Medical Imaging Market Share 2025, by Region

North America

43.0%

South America

xx%

Europe

24.0%

Middle East Africa

xx%

Asia Pacific

xx%

North America held the largest market position in 2025, supported by the strong presence of AI medical imaging companies, well-established regulatory frameworks, advanced healthcare infrastructure, and early adoption of AI-powered diagnostic solutions. The United States remains the primary regional market, driven by its mature healthcare technology ecosystem, strong presence of AI-native imaging companies such as Aidoc and Viz.ai, and established medical imaging manufacturers including GE HealthCare and Philips. High demand for faster diagnostic workflows and AI-assisted image interpretation is further supporting adoption across hospitals and diagnostic facilities. Canada is also contributing to regional growth through the integration of AI into hospitals, academic medical centers, and research institutions, with increasing focus on improving diagnostic efficiency, clinical decision-making, and access to advanced imaging technologies. Together, the United States and Canada are strengthening North America's position as a leading market for AI-based medical imaging innovation and adoption.

Asia Pacific is projected to grow at the fastest CAGR during the forecast period, driven by expanding healthcare infrastructure, government-led screening initiatives, faster adoption of advanced medical technologies, and increasing investment in diagnostic imaging across the region. China is emerging as a major AI medical imaging market, supported by strong government focus on artificial intelligence, domestic healthcare technology development, and the integration of AI into hospitals and diagnostic workflows. India is experiencing growing demand for AI-assisted imaging as its healthcare system expands diagnostic capacity, improves access to advanced medical technologies, and addresses the needs of a large and diverse patient population. Japan is supported by its highly developed healthcare system, advanced medical imaging infrastructure, aging population, and strong emphasis on using AI to improve diagnostic efficiency and support clinical decision-making. South Korea is benefiting from its technologically advanced healthcare ecosystem, strong medical AI development capabilities, and increasing integration of AI-based imaging solutions across hospitals and specialized diagnostic centers. Together, these markets are supporting the rapid expansion of AI-based medical imaging adoption across Asia Pacific.

Countries and Regions Covered

North America (Largest Region)

• United States (Largest Country Market)
• Canada
• Mexico

Europe

• Germany (Largest Country Market)
• United Kingdom
• France
• Italy
• Rest of Europe

Asia Pacific (Fastest-Growing Region)

• China (Largest Country Market)
• India (Fastest-Growing Country Market)
• Japan
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil (Largest Country Market)
• Chile
• Rest of Latin America

Middle East & Africa

• Saudi Arabia (Largest Country Market)
• United Arab Emirates
• Rest of Middle East & Africa

Market Share

The AI-Based Medical Imaging Market is fragmented and rapidly consolidating, spanning large, diversified imaging equipment OEMs , GE HealthCare, Siemens Healthineers, Koninklijke Philips, and Canon Medical Systems that embed AI capabilities across their full imaging hardware stack, and a large cohort of AI-native pure-play vendors such as Aidoc, Viz.ai, and Qure.ai that compete primarily on breadth of FDA-cleared indications and speed of clinical workflow integration. Large technology platform companies including Microsoft, IBM, Intel, and NVIDIA participate both as infrastructure providers and as increasingly direct investors in AI-native imaging startups, as illustrated by NVIDIA's venture participation in Aidoc's 2026 funding round. Oncology-focused pathology imaging is emerging as a distinct competitive sub-category, with Tempus AI's 2025 acquisition of Paige signaling continued consolidation activity. Key success factors include the breadth of FDA-cleared clinical indications, depth of integration with hospital picture archiving and communication systems, and demonstrated impact on clinical turnaround time and patient outcomes.

Key Players

• GE HealthCare Technologies Inc. (US)
• Koninklijke Philips N.V. (Netherlands)
• Siemens Healthineers AG (Germany)
• Canon Medical Systems Corporation (Japan)
• Agfa-Gevaert Group / Agfa HealthCare (Belgium)
• Microsoft Corporation (US)
• Intel Corporation (US)
• NVIDIA Corporation (US)
• Aidoc Medical Ltd. (Israel)
• Viz.ai, Inc. (US)
• Nanox Imaging Ltd. (Israel)
• Tempus AI, Inc. (US)
• PathAI, Inc. (US)
• Enlitic, Inc. (US)
• Butterfly Network, Inc. (US)

Recent Market Developments

• November 2025: GE HealthCare announced its $2.3 billion acquisition of Intelerad, strengthening its cloud-based and AI-enabled medical imaging portfolio and expanding its capabilities in connected imaging workflows.
• February 2025: Philips launched SmartSpeed Precise, a dual-AI MRI technology designed to accelerate scans and enhance image quality, strengthening Philips’ position in AI-powered medical imaging.
• November 2025: Butterfly Network launched Compass AI, an AI-powered platform designed to streamline point-of-care ultrasound workflows and support scalable imaging programs, strengthening the company’s position in AI-enabled medical imaging.

Frequently Asked Questions

Key Questions Answered

Request a Sample

1

What is AI-Based Medical Imaging?

2

What is the CAGR of the AI-Based Medical Imaging Market?

3

Which AI technology leads the AI-Based Medical Imaging Market?

4

Which imaging modality dominates the AI-Based Medical Imaging Market?

5

Which application dominates the AI-Based Medical Imaging Market?

6

What are the latest trends in the AI-Based Medical Imaging Market?

7

Who are the key players in the AI-Based Medical Imaging Market?

Why Choose IG Transformation

Speak to Analyst

Strong Industry Focus

Extensive Product Offerings

Customer Research Services

Robust Research Methodology

Comprehensive Reports

Latest Technological Developments

Value Chain Analysis

Potential Market Opportunities

Growth Dynamics

Quality Assurance

Post-sales Support

Regular Report Updates